Navigation Links
Novel 'antisense' therapies protect primates from lethal Ebola and Marburg viruses
Date:8/22/2010

New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposuresuggesting the approach holds promise for treating accidental infections in laboratory or hospital settings.

The research, which appears in today's online edition of the journal Nature Medicine, was conducted by the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with AVI BioPharma, a Washington-based biotechnology firm.

Working with a class of compounds known as antisense phosphorodiamidate morpholino oligomers, or PMOs, scientists first performed a series of studies with mouse and guinea pig models of Ebola to screen various chemical variations. They arrived at a therapy known as AVI-6002, which demonstrated a survival rate of better than 90 percent in animals treated either pre- or post-exposure.

Encouraged by these results, the team conducted "proof of concept" studies in which 9 rhesus monkeys were challenged with lethal Ebola virus. Treatment was initiated 30-60 minutes after exposure to the virus. In these studies, 5 of 8 monkeys survived, while the remaining animal was untreated. Further experiments, including a multiple-dose evaluation, also yielded promising results, with 3 of 5 monkeys surviving in each of the AVI-6002 treatment groups when they received a dose of 40 mg per kg of body weight.

According to first author Travis K. Warren of USAMRIID, antisense drugs are useful against viral diseases because they are designed to enter cells and eliminate viruses by preventing their replication. The drugs act by blocking critical viral genetic sequences, essentially giving the infected host time to mount an immune response and clear the virus.

Ebola and Marburg cause hemorrhagic fever with case fatality rates as high as 90 percent in humans. The v
'/>"/>

Contact: Caree Vander Linden
caree.vander-linden@amedd.army.mil
US Army Medical Research Institute of Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Novel bee venom derivative forms a nanoparticle smart bomb to target cancer cells
2. UM researcher identifies novel treatment for pain in sickle cell disease
3. Novel microfluidic HIV test is quick and cheap
4. NIH-supported study finds novel pathway may open doors for new blood pressure treatments
5. Novel protein essential for successful pregnancy
6. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
7. Novel processing technologies developed for extending use of oats in gluten-free diet
8. Novel strategy for generating induced pluripotent stem cells for clinical use is safe and efficient
9. International research team discovers novel genes influencing kidney disease risk
10. Researchers use novel nanoparticle vaccine to cure type 1 diabetes in mice
11. Pitt-led international study identifies human enzyme that breaks down potentially toxic nanomaterials, opens door to novel drug delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2015)... Deutschland und GERMANTOWN, Maryland , June ... ®   Produktlinie mit DNA-Tests verbessert den ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) hat ... STR-Testkits der Produktlinie Investigator ® ... Markt eingeführt. Die neuen Kits zur Erstellung genetischer Fingerabdrücke ...
(Date:6/16/2015)... 16, 2015  With the increasing number and severity ... top concern. The recent compromise of Federal employee ... strong authentication within government agencies. HYPR Corp. ... password (OTP) authenticator, has been submitted for testing and ... 3 validation for tamper proofing. The ...
(Date:6/15/2015)... Conn. , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces that ... be showcased to media at Digital Experience! @ NYC June ... summer showcase of the latest innovation in technology to over ... will be held at the Metropolitan Pavilion in ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... (FASD) and Fetal alcohol syndrome (FAS) cause malformations ... mental and behavioral abnormalities. The African frog, Xenopus, ... development since these embryos are large, easy to ... New research uses this system to address ...
... "Digital Fingerprinting for Kids" event on April 18 at ... Beach CHESAPEAKE, Va., April 2 Turner Network ... Broadcasting System, Inc. (TBS, Inc.), and truTV, are partnering with ... highly-regarded "Digital Fingerprinting for Kids" event , a service ...
... By identifying a novel compound that primes a plant,s immune ... of Chicago may be on a path to developing disease-resistant ... a team that includes Tim Tschaplinski of the Department of ... priming the immunity response in Arabidopsis, a small flowering plant ...
Cached Biology News:Frogs reveal clues about the effects of alcohol during development 2truTV and Cox Offer Free Digital Fingerprinting to Help Prevent Crimes Against Children 2truTV and Cox Offer Free Digital Fingerprinting to Help Prevent Crimes Against Children 3Researchers discover primer to plant defense system 2
(Date:6/29/2015)... ... June 29, 2015 , ... ... around 19% during the forecast period (2015 to 2020). The market is mainly ... government and corporate funding for R&D. However, lack of adequate healthcare and research ...
(Date:6/29/2015)... , June 29, 2015  Neuralstem, Inc. (NYSE ... technology to develop small molecule and cell therapy treatments ... has been approved for listing on the NASDAQ Capital ... will continue to trade on the NYSE MKT until ... the NASDAQ Capital Market is expected to commence on ...
(Date:6/29/2015)... NEW YORK , June 29, 2015   For ... of life sciences to assess their overall digital maturity ... to show that these companies are not maturing fast ... the healthcare industry in numerous ways overall and customers ... industries in terms of digital customer engagement.  ...
(Date:6/26/2015)... VANCOUVER , June 26, 2015 /PRNewswire/ - iCo ... ICOTF), today announced that all nominees listed in ... as directors at its 2015 Annual Meeting of ... a vote by ballot, the following 5 nominees ... iCo Therapeutics to serve until the Company,s next ...
Breaking Biology Technology:Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3
... initiatives, open model of information sharing, ... ... The Duke University Health,System has licensed Velos eResearch to ... Velos, Inc. will,play a key role in these clinical trials ...
... Initiate Process to Re-list Common Shares, SOUTH ... Sheets: VXGN) announced today that it has filed ... 2007, thereby bringing the company current,on its financial ... (SEC). (Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) Accordingly, ...
... (Nasdaq: MLNM ) today announced the election ... of Directors. Dr. Leiden, a,Managing Director at Clarus ... distinguished career of more than 20 years of ... joining Clarus, Dr. Leiden,served as President and Chief ...
Cached Biology Technology:Velos eResearch System License Agreement Announced 2Velos eResearch System License Agreement Announced 3Velos eResearch System License Agreement Announced 4Velos eResearch System License Agreement Announced 5VaxGen Files Last Outstanding Periodic Report With SEC 2Life Sciences Leader Joins Millennium Board of Directors 2Life Sciences Leader Joins Millennium Board of Directors 3
HybriWell seals securely to a microscope slide surface in seconds to enclose single or multiple specimens in a small reagent volume and eliminate evaporation....
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... Human IgM Assay Kit to address the ... assay for Human IgM that eliminates the ... a simple mix-and-read assay that allows the ... ng/ml in approximately 30 minutes. The Pierce ...
AC input: 230 V...
Biology Products: